(A) RT-PCR analysis of SDIA-treated ES cells (day 8). Lane 1, embryonic day (E)10.5 embryo; lanes 2 and 3, SDIA-treated ES cells without and with 0.2 μM RA treatment during days 4–8, respectively. (B) Percent immunoreactive cells/total cells are shown. (C–E) BMP4 (0.5 nM) treatment during the days indicated above. Positive colonies were defined as ones containing TuJ1+ (C), TH+/Peri− (D), and TH+/Peri+ (E) cells. Lane 1, control, no BMP4 treatment. (F) RT-PCR analysis with neural crest and neural markers. Lane 1, E10.5 whole embryos; lanes 2 and 3, SDIA-treated ES cells without or with 5 nM BMP4 treatment during days 5–8, respectively. (G) Ncx expression in E11.5 mouse by in situ hybridization. Dorsal root (arrow) and sympathetic (arrowhead) ganglia. (H) SDIA/BMP-treated ES cell colonies (day 8). (I) SDIA-treated ES cell colonies. (J) Percentages of Ncx+ colonies at 0, 0.5, and 5 nM BMP4 (n = 100, 200, and 200, respectively). *, P < 0.005 vs. control; **, P < 0.005 vs. control.